Jerry J Buccafussco

Summary

Affiliation: Medical College of Georgia
Country: USA

Publications

  1. ncbi Neuroprotective effects and mechanism of cognitive-enhancing choline analogs JWB 1-84-1 and JAY 2-22-33 in neuronal culture and Caenorhabditis elegans
    Roongpetch Keowkase
    Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Mol Neurodegener 5:59. 2010
  2. ncbi The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys
    Jerry J Buccafusco
    Alzheimer s Research Center, Medical College of Georgia, Augusta, GA 30912, USA
    Neuropharmacology 46:10-22. 2004
  3. ncbi Sex dimorphisms in the cognitive-enhancing action of the Alzheimer's drug donepezil in aged Rhesus monkeys
    J J Buccafusco
    Alzheimer s Research Center, Medical College of Georgia, and the Veterans Administration Medical Center, Augusta, GA 30912, USA
    Neuropharmacology 44:381-9. 2003
  4. ncbi Autoimmunity in Alzheimer's disease as evidenced by plasma immunoreactivity against RAGE and Abeta42: complication of diabetes
    Shyamala Mruthinti
    Alzheimer s Research Center, Department of Pharmacology and Toxicology, Medical College of GA, Augusta, Georgia 30912, USA
    Curr Alzheimer Res 3:229-35. 2006
  5. ncbi A computer-assisted cognitive test battery for aged monkeys
    Jerry J Buccafusco
    Alzheimer s Research Center, Medical College of Georgia, Augusta 30912, USA
    J Mol Neurosci 19:179-85. 2002
  6. ncbi Potential cognitive actions of (n-propargly-(3r)-aminoindan-5-yl)-ethyl, methyl carbamate (tv3326), a novel neuroprotective agent, as assessed in old rhesus monkeys in their performance of versions of a delayed matching task
    J J Buccafusco
    Alzheimer s Research Center, Medical College of Georgia, 30912 2300, Augusta, GA, USA
    Neuroscience 119:669-78. 2003
  7. ncbi Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats
    J J Buccafusco
    Alzheimer s Research Center, Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta 30912 2300, USA
    Brain Res 852:76-83. 2000
  8. ncbi Differential improvement in memory-related task performance with nicotine by aged male and female rhesus monkeys
    J J Buccafusco
    Department of Pharmacology and Toxicology, Medical College of Georgia, The Veterans Affairs Medical Center, Augusta 30912 2300, USA
    Behav Pharmacol 10:681-90. 1999
  9. ncbi Multiple central nervous system targets for eliciting beneficial effects on memory and cognition
    J J Buccafusco
    Department of Pharmacology and Toxicology, Alzheimer s Research Center, Augusta, Georgia, USA
    J Pharmacol Exp Ther 295:438-46. 2000
  10. ncbi Deficits in spatial learning and nicotinic-acetylcholine receptors in older, spontaneously hypertensive rats
    A V Terry
    University of Georgia College of Pharmacy, Medical College of Georgia, Augusta, GA 30912, USA
    Neuroscience 101:357-68. 2000

Collaborators

Detail Information

Publications53

  1. ncbi Neuroprotective effects and mechanism of cognitive-enhancing choline analogs JWB 1-84-1 and JAY 2-22-33 in neuronal culture and Caenorhabditis elegans
    Roongpetch Keowkase
    Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Mol Neurodegener 5:59. 2010
    ..The purpose of these experiments was to more specifically investigate the neuroprotective capabilities of these lead compounds both in vitro and in vivo...
  2. ncbi The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys
    Jerry J Buccafusco
    Alzheimer s Research Center, Medical College of Georgia, Augusta, GA 30912, USA
    Neuropharmacology 46:10-22. 2004
    ..They also indicate that the drug is associated with long-term effects that could limit dosing regimens to one dose every two or three days. The nature of the protracted mnemonic effects produced by the compound remains to be elucidated...
  3. ncbi Sex dimorphisms in the cognitive-enhancing action of the Alzheimer's drug donepezil in aged Rhesus monkeys
    J J Buccafusco
    Alzheimer s Research Center, Medical College of Georgia, and the Veterans Administration Medical Center, Augusta, GA 30912, USA
    Neuropharmacology 44:381-9. 2003
    ..These findings support the concept that aged males and females respond differently to this class of agents, perhaps representing fundamental sex-related differences in memory processing, or in the manner that age affects these processes...
  4. ncbi Autoimmunity in Alzheimer's disease as evidenced by plasma immunoreactivity against RAGE and Abeta42: complication of diabetes
    Shyamala Mruthinti
    Alzheimer s Research Center, Department of Pharmacology and Toxicology, Medical College of GA, Augusta, Georgia 30912, USA
    Curr Alzheimer Res 3:229-35. 2006
    ..For both diseases one underlying contributing factor to cytotoxicity could be the development of an autoimmune response triggered by the presence of AGEs and amyloid peptides...
  5. ncbi A computer-assisted cognitive test battery for aged monkeys
    Jerry J Buccafusco
    Alzheimer s Research Center, Medical College of Georgia, Augusta 30912, USA
    J Mol Neurosci 19:179-85. 2002
    ..08). If the titrating version of the DMTS is sensitive to mnemonic drugs, the task may prove useful for drug comparisons with aging...
  6. ncbi Potential cognitive actions of (n-propargly-(3r)-aminoindan-5-yl)-ethyl, methyl carbamate (tv3326), a novel neuroprotective agent, as assessed in old rhesus monkeys in their performance of versions of a delayed matching task
    J J Buccafusco
    Alzheimer s Research Center, Medical College of Georgia, 30912 2300, Augusta, GA, USA
    Neuroscience 119:669-78. 2003
    ..TV3326 was not associated with any obvious side effect or untoward reaction of the animals to the drug. Thus, TV3326 may be expected to offer a significant positive cognitive outcome in addition to its reported neuroprotective action...
  7. ncbi Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats
    J J Buccafusco
    Alzheimer s Research Center, Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta 30912 2300, USA
    Brain Res 852:76-83. 2000
    ....
  8. ncbi Differential improvement in memory-related task performance with nicotine by aged male and female rhesus monkeys
    J J Buccafusco
    Department of Pharmacology and Toxicology, Medical College of Georgia, The Veterans Affairs Medical Center, Augusta 30912 2300, USA
    Behav Pharmacol 10:681-90. 1999
    ..Therefore, aged female subjects may require a greater level of individualized treatment and perhaps higher doses of nicotinic agonists to achieve the maximal mnemonic benefit...
  9. ncbi Multiple central nervous system targets for eliciting beneficial effects on memory and cognition
    J J Buccafusco
    Department of Pharmacology and Toxicology, Alzheimer s Research Center, Augusta, Georgia, USA
    J Pharmacol Exp Ther 295:438-46. 2000
    ..Thus, certain memory-enhancing agents may prove more useful when implemented early in the course of a disease such as AD, and they also may enjoy a wide application for the treatment of the memory decline associated with normal aging...
  10. ncbi Deficits in spatial learning and nicotinic-acetylcholine receptors in older, spontaneously hypertensive rats
    A V Terry
    University of Georgia College of Pharmacy, Medical College of Georgia, Augusta, GA 30912, USA
    Neuroscience 101:357-68. 2000
    ....
  11. ncbi Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists
    R R Jonnala
    Alzheimer's Research Center, Medical College of Georgia, Augusta, Georgia 30912-2300, USA
    J Neurosci Res 66:565-72. 2001
    ..Thus the induced upregulation of the alpha7 subtype of nicotinic receptors during chronic exposure to nicotine may be responsible for the drug's neuroprotective action...
  12. ncbi Repeated, intermittent exposures to diisopropylfluorophosphate in rats: protracted effects on cholinergic markers, nerve growth factor-related proteins, and cognitive function
    A V Terry
    Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA 30912, USA
    Neuroscience 176:237-53. 2011
    ....
  13. ncbi Dahl salt-sensitive and salt-resistant rats: examination of learning and memory performance, blood pressure, and the expression of central nicotinic acetylcholine receptors
    A V Terry
    Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, CJ 1020, Medical College of Georgia, Augusta, GA 30912, USA
    Neuroscience 103:351-63. 2001
    ....
  14. ncbi The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products
    S Mruthinti
    Alzheimer s Research Center, Department of Pharmacology and Toxicology, Medical College of Georgia, 1120 15th Street, Augusta, GA 30912, USA
    Neuroscience 142:463-73. 2006
    ..These results are consistent with the ability of AGEs to enhance the cell surface expression of diverse Abeta42 binding sites, a factor that can lead to the enhanced binding of amyloid and subsequent cell death...
  15. ncbi Spinal muscarinic cholinergic and nitric oxide systems in cardiovascular regulation
    D S Feldman
    Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta 30912 2300, USA
    Eur J Pharmacol 313:211-20. 1996
    ....
  16. ncbi A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: Pharmacological modification by arecoline
    J J Buccafusco
    Veterans Administration Medical Center, Augusta, GA 30904, USA
    Neuroscience 149:487-98. 2007
    ..The results of this study support the role of cholinergic systems in self-administration behavior and context-induced post-withdrawal drug seeking...
  17. ncbi Repeated exposures to low-level chlorpyrifos results in impairments in sustained attention and increased impulsivity in rats
    M L Middlemore-Risher
    Program of Clinical and Experimental Therapeutics, University of Georgia, College of Pharmacy, Augusta, GA, 30912, United States
    Neurotoxicol Teratol 32:415-24. 2010
    ..These results indicate that repeated exposures to relatively low levels of chlorpyrifos lead to protracted impairments of sustained attention and an increase in impulsive behaviors in rats...
  18. ncbi Inhibition of nerve growth factor signaling by peroxynitrite
    R R Jonnala
    Alzheimer Research Center, Department of Pharmacology and Toxicology, Department of Veterans Affairs Medical Center, Medical College of Georgia, Augusta, Georgia 30912-2300, USA
    J Neurosci Res 63:27-34. 2001
    ..The inactivation of TrkA receptors may contribute to the initial insult that eventually leads to neuronal cell death...
  19. ncbi The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development
    A V Terry
    Program in Clinical and Experimental Therapeutics, University of Georgia, Augusta, GA 30912 2450, USA
    J Pharmacol Exp Ther 306:821-7. 2003
    ..Therefore, cholinergic-based strategies will likely remain valid as one approach to rational drug development for the treatment of AD other forms of dementia...
  20. ncbi Repeated exposures to subthreshold doses of chlorpyrifos in rats: hippocampal damage, impaired axonal transport, and deficits in spatial learning
    A V Terry
    Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy Augusta Campus, Medical College of Georgia, Augusta, Georgia 30912, USA
    J Pharmacol Exp Ther 305:375-84. 2003
    ..Some of these symptoms may be attributed to effects of the OP on axonal transport...
  21. ncbi Effectiveness of alpha 2-adrenergic receptor stimulation in reducing the central toxicity following cholinesterase inhibition
    J J Buccafusco
    Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta 30912
    Res Commun Chem Pathol Pharmacol 75:85-98. 1992
    ....
  22. ncbi Effects of (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys
    A V Terry
    Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Medical College of Georgia, Augusta, Georgia 309 12, USA
    J Pharmacol Exp Ther 301:284-92. 2002
    ..Collectively, the present data suggest that in specific conditions SIB-1553A may improve certain aspects of attentional function in young adult rats and nonhuman primates without adverse side effects...
  23. ncbi Cocaine-induced expression differences in glutamate receptor subunits and transporters in amygdalae of taste aversion-prone and taste aversion-resistant rats
    R L Elkins
    Department Psychiatry and Health Behavior, Medical College of Georgia, Augusta, Georgia 30912, USA
    Ann N Y Acad Sci 1003:381-5. 2003
  24. ncbi Cocaine-induced expression differences in PSD-95/SAP-90-associated protein 4 and in Ca2+/calmodulin-dependent protein kinase subunits in amygdalae of taste aversion-prone and taste aversion-resistant rats
    R L Elkins
    Department Psychiatry and Health Behavior, Medical College of Georgia, Augusta, Georgia 30912, USA
    Ann N Y Acad Sci 1003:386-90. 2003
  25. ncbi Relative levels of cytoprotection produced by analogs of choline and the role of alpha7-nicotinic acetylcholine receptors
    Ramamohana R Jonnala
    Alzheimer's Research Center, Medical College of Georgia, Augusta, Georgia 30912-2300l, USA
    Synapse 47:262-9. 2003
    ....
  26. ncbi Chlorpyrifos, chlorpyrifos-oxon, and diisopropylfluorophosphate inhibit kinesin-dependent microtubule motility
    Debra A Gearhart
    Department of Pharmacology and Toxicology, 1120 Fifteenth Street, Medical College of Georgia, Augusta, GA 30912 2300, USA
    Toxicol Appl Pharmacol 218:20-9. 2007
    ..We postulate that disruption of kinesin-dependent intracellular transport could account for some of the long-term effects of organophosphates on the peripheral and central nervous system...
  27. ncbi Disconnection between activation and desensitization of autonomic nicotinic receptors by nicotine and cotinine
    Jerry J Buccafusco
    Department of Pharmacology and Toxicology, Alzheimer s Research Center, Medical College of Georgia, Augusta, GA 30912 2300, United States
    Neurosci Lett 413:68-71. 2007
    ....
  28. ncbi MHP-133, a drug with multiple CNS targets: potential for neuroprotection and enhanced cognition
    Jerry J Buccafusco
    Alzheimer s Research Center, Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA 30912, USA
    Neurochem Res 32:1224-37. 2007
    ..The results of this study are consistent with the potential use of MHP-133 in the treatment of neurodegenerative disorders such as Alzheimer's disease...
  29. ncbi Chronic, intermittent exposure to chlorpyrifos in rats: protracted effects on axonal transport, neurotrophin receptors, cholinergic markers, and information processing
    Alvin V Terry
    Department of Pharmacology and Toxicology, University of Georgia College of Pharmacy, Augusta, Georgia 30912 2300, USA
    J Pharmacol Exp Ther 322:1117-28. 2007
    ..Such neurochemical changes may lead to deficits in information processing and cognitive function...
  30. ncbi Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides
    Shyamala Mruthinti
    Alzheimer's Research Center, Medical College of Georgia, Augusta, GA 30912, USA
    Neurobiol Aging 25:1023-32. 2004
    ..The close relationship between titers for Abeta and RAGE IgGs suggests the possibility that the antibodies are being produced in response to a common mechanism or protein complex (with the respective epitopes) linked to the disease...
  31. ncbi Nicotine increases the expression of high affinity nerve growth factor receptors in both in vitro and in vivo
    Ramamohana R Jonnala
    Alzheimer's Research Center, Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta 30912, USA
    Life Sci 70:1543-54. 2002
    ....
  32. ncbi The effects of JWB1-84-1 on memory-related task performance by amyloid Abeta transgenic mice and by young and aged monkeys
    Ajay Sood
    Alzheimer s Research Center, Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA 30912, USA
    Neuropharmacology 53:588-600. 2007
    ..Its cytoprotective action might also work to slow the progression of Alzheimer's disease...
  33. ncbi Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys
    Jerry J Buccafusco
    Department of Pharmacology and Toxicology, Alzheimer s Research Center, Medical College of Georgia, Augusta, GA 30912, USA
    Biochem Pharmacol 74:1202-11. 2007
    ....
  34. ncbi Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine
    Alvin V Terry
    Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Medical College of Georgia, Augusta, GA 30910, USA
    Psychopharmacology (Berl) 162:292-300. 2002
    ..Muscarinic-acetylcholine receptor agonists are yet to be used clinically for the treatment of Alzheimer's disease (AD) even though laboratory evidence continues to support the potential for such an approach...
  35. ncbi Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition
    Alvin V Terry
    Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy (Augusta Campus, Medical College of Georgia, Augusta, GA 30912-2300, USA
    CNS Drug Rev 11:229-52. 2005
    ..Based on its relative safety in man, cotinine should prove useful in the treatment of diseases of impaired cognition and behavior without exhibiting the toxicity usually attributed to nicotine...
  36. ncbi Effect of amyloid peptides on the increase in TrkA receptor expression induced by nicotine in vitro and in vivo
    Xinyu D Li
    Alzheimer s Research Center, Medical College of Georgia, Augusta, GA, USA
    J Mol Neurosci 27:325-36. 2005
    ..Therefore, physiologically relevant concentrations of Abeta1-42 can prevent nicotine-induced TrkA receptor expression in brain regions containing cholinergic neurons susceptible to the neurotoxicity associated with Alzheimer's disease...
  37. ncbi Neuronal nicotinic receptor subtypes: defining therapeutic targets
    Jerry J Buccafusco
    Alzheimer s Research Center, Medical College of Georgia, 1120 15 Street, Augusta, Georgia 30912 2300, USA
    Mol Interv 4:285-95. 2004
    ..For both families of cholinergic receptors, widespread exploitation in terms of therapeutics has been limited by significant side effect profiles associated with available cholinergic drugs...
  38. ncbi Donepezil-induced improvement in delayed matching accuracy by young and old rhesus monkeys
    Jerry J Buccafusco
    Alzheimer s Research Center, Medical College of Georgia, Augusta, GA 30912, USA
    J Mol Neurosci 24:85-91. 2004
    ..Yet at doses that were effective in all subjects, there was no relationship between age and the improvement in task accuracy. Likewise, there was no association between baseline task proficiency and improvement in task accuracy...
  39. ncbi The importance of brainstem cholinergic neurons in the pressor response to cocaine
    Jerry J Buccafusco
    Alzheimer s Research Center, Department of Pharmacology and Toxicology, 1120 15th St, Augusta, GA 30912 2300, USA
    J Pharmacol Exp Ther 312:179-91. 2005
    ....
  40. ncbi The potential role of cotinine in the cognitive and neuroprotective actions of nicotine
    Jerry J Buccafusco
    Alzheimer s Research Center, Medical College of Georgia, Augusta, GA 30912, USA
    Life Sci 72:2931-42. 2003
    ....
  41. ncbi Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys
    Alvin V Terry
    Program in Clinical and Experimental Therapeutics, CJ 1020 The Medical College of Georgia, University of Georgia College of Pharmacy Augusta Campus, Augusta, GA 30912, USA
    Psychopharmacology (Berl) 179:725-32. 2005
    ....
  42. ncbi Relationship between the induction of RAGE cell-surface antigen and the expression of amyloid binding sites
    Shyamala Mruthinti
    lzheimer s Research Center, Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA 30912, USA
    J Mol Neurosci 20:223-32. 2003
    ..Thus, the time-dependent formation of AGEs might play a role within the context of the immune system in the expression of binding sites for amyloid peptides, possibly resulting in enhancing cellular toxicity...
  43. ncbi Effect of beta-amyloid peptide 1-42 on the cytoprotective action mediated by alpha7 nicotinic acetylcholine receptors in growth factor-deprived differentiated PC-12 cells
    Xinyu D Li
    Alzheimer's Research Center, Medical College of Georgia, Augusta, GA 30912-2300, USA
    J Pharmacol Exp Ther 307:670-5. 2003
    ....
  44. ncbi Novel analogs of choline as potential neuroprotective agents
    Jerry J Buccafusco
    Alzheimer s Research Center, Medical College of Georgia, Augusta, GA 30912, USA
    J Alzheimers Dis 6:S85-92. 2004
    ....
  45. ncbi Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance
    Jerry J Buccafusco
    Department of Pharmacology and Toxicology, Alzheimer s Research Center, Medical College of Georgia, Augusta, GA 30912, USA
    Trends Pharmacol Sci 26:352-60. 2005
    ..A better understanding of this phenomenon might shed new light on the role of nAChR systems in memory formation and retrieval...
  46. ncbi Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential
    John N Bain
    Alzheimer's Research Center, Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA 30912-2300, USA
    Psychopharmacology (Berl) 169:150-60. 2003
    ....
  47. ncbi Functional central nicotinic acetylcholine receptor antagonism by systemic administration of Tinuvin 770 (BTMPS)
    John H Graham
    Medical College of Georgia, Alzheimer's Research Center, Augusta, GA 30912-2300, USA
    Curr Alzheimer Res 2:141-7. 2005
    ..Therefore, BTMPS can be considered as an alternative to or as a confirmatory drug for mecamylamine when inhibition of central nicotinic receptors is required...
  48. ncbi Role of alpha7 nicotinic acetylcholine receptors in the pressor response to intracerebroventricular injection of choline: blockade by amyloid peptide Abeta1-42
    Xinyu D Li
    Department of Pharmacology and Toxicology, Alzheimer's Research Center, Medical College of Georgia, Augusta, GA 30912-2300, USA
    J Pharmacol Exp Ther 309:1206-12. 2004
    ..c.v. route significantly inhibited the choline-induced blood pressure increase as well as the choline-induced decrease in heart rate...
  49. ncbi The electromyographic signal as a presymptomatic indicator of organophosphates in the body
    Carlo J De Luca
    Delsys, Inc, P O Box 15734, Boston, Massachusetts, USA
    Muscle Nerve 33:369-76. 2006
    ..These findings can lead to the development of noninvasive technology for indicating the presence of OP compounds in muscle tissue prior to clinical abnormalities...
  50. ncbi Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders
    Moussa B H Youdim
    Eve Topf and US National Parkinson Foundation, Centers of Excellence for Neurodegenerative Diseases Research, Technion Rappaport Faculty of Medicine and Department of Pharmacology, Haifa 31096, Israel
    Trends Pharmacol Sci 26:27-35. 2005
    ..These bi- or multi-functional compounds might provide greater symptomatic efficacy, and better utility as potential neuroprotective disease-modifying drugs...
  51. ncbi Guidelines on nicotine dose selection for in vivo research
    Shannon G Matta
    Department of Pharmacology, College of Medicine, University of Tennessee Health Science Center, 874 Union Avenue, Crowe 115, Memphis, TN 38163, USA
    Psychopharmacology (Berl) 190:269-319. 2007
    ..In many cases, such discrepancies could be attributed to the complex variables comprising species-specific in vivo responses to acute or chronic nicotine exposure...
  52. ncbi Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder
    Paul Abrams
    Bristol Urological Institute, Southmead Hospital, Westbury on Trym, Bristol BS10 5NB
    Br J Pharmacol 148:565-78. 2006
    ..Further research is needed to show whether the M3 selective receptor antagonists have any advantage over less selective drugs, in leading to fewer adverse events...
  53. ncbi Hippocampal CA1 cell loss in a non-human primate model of transient global ischemia: a pilot study
    Koichi Hara
    Department of Neurology, Medical College of Georgia, Augusta, GA 30912, USA
    Brain Res Bull 74:164-71. 2007
    ..Additional studies are warranted to reveal behavioral deficits associated with this ischemia model...